Open Access
Patient perception of voxelotor treatment benefit in sickle cell disease
Modupe Idowu, Anam Haque, Elisa M Williams, Arthi Sridhar
DOI: 10.1136/jim-2021-002215 Published 22 June 2022
Modupe Idowu
1
Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
Anam Haque
2
The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
Elisa M Williams
2
The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
Arthi Sridhar
1
Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA

Submit a Response to This Article
No eLetters have been published for this article.
Patient perception of voxelotor treatment benefit in sickle cell disease
Modupe Idowu, Anam Haque, Elisa M Williams, Arthi Sridhar
Journal of Investigative Medicine Jun 2022, 70 (5) 1316-1319; DOI: 10.1136/jim-2021-002215